EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+23.5%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$268M
AUM Growth
+$268M
(+43%)
Cap. Flow
+$32.6M
Cap. Flow
% of AUM
12.15%
Top 10 Holdings %
Top 10 Hldgs %
81.64%
Holding
26
New
4
Increased
5
Reduced
4
Closed
4
Top Buys
1 |
EPZM
Epizyme, Inc
EPZM
|
$29.7M |
2 |
Atara Biotherapeutics
ATRA
|
$28.2M |
3 |
Salarius Pharmaceuticals
SLRX
|
$15.8M |
4 |
Travere Therapeutics
TVTX
|
$9.82M |
5 |
Assembly Biosciences
ASMB
|
$7.47M |
Top Sells
1 |
SAGE
Sage Therapeutics
SAGE
|
$19M |
2 |
MacroGenics
MGNX
|
$15.9M |
3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$10.5M |
4 |
KITE
Kite Pharma, Inc.
KITE
|
$9.06M |
5 |
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
|
$3.44M |
Sector Composition
1 | Healthcare | 69.48% |